Drugmaker Recalls Arthritis Medication

WASHINGTON - ESI Lederle announced last Thursday that it was recalling 4.2 million capsules of the arthritis drug etodolac because of contamination that could cause life-threatening complications in patients with heart conditions.

The company said that the recall will cover one lot of 300-milligram capsules, No. 9991052, which were distributed nationwide. For more information visit www.fda.gov.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish